Faaborg Pharma - IP ApS: Financial statements 2025
CVR: 43517252
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Faaborg Pharma - IP ApS (CVR 43517252) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 75,860 and a net result of DKK -678,796 compared with DKK -895,356 the year before. Equity in the 2025 report amounted to DKK -2,291,658.
- Gross Profit
- DKK 75,860
- Profit/Loss
- DKK -678,796
- Equity
- DKK -2,291,658
- Total Assets
- DKK 2,133,431
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 76 t. | -679 t. | -2.3 mio. | 0 |
| 2024 | - | -248 t. | -895 t. | -1.6 mio. | 0 |
Official annual report
How creditworthy is Faaborg Pharma - IP ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Faaborg Pharma - IP ApS has published its annual report for 2024. Gross profit came to DKK -247,665, and the net result was DKK -895,356.
About Faaborg Pharma - IP ApS
Faaborg Pharma - IP ApS is a Danish company of the type Anpartsselskab based in Faaborg, founded in 2022. The company is registered under the industry Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker. The management consists of Jan Knudsen. The board consists of Claus Wædeled (chair), Birk Simon Maldonado Andersen and Jan Knudsen. The company is owned by Faaborg Løve Produkter Holding I ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 75,860 and a net result of DKK -678,796 compared with DKK -895,356 the year before. Equity in the 2025 report amounted to DKK -2,291,658.